Proteins

#Blood clotting #Fibrinogen #Proteins #The University of Manchester #Wound care #Wound healing

Fibrinogen discovery reshapes our understanding of how wounds heal

Scientists have redefined how the key blood‑clotting protein fibrinogen behaves when it contacts air, overturning two decades of scientific consensus on wound healing. The study, ‘Redefining Fibrinogen Self Assembly at the Air–Water Interface: An Intriguing Story with Multiple Layers’, is the culmination of over a decade of international collaboration by… Read More

#News

Protein degrader
#Avenue Biosciences #Circio Holding #Disease treatment #Gene therapy #Proteins #Synergistic technology

Research collaboration to enhance protein secretion for gene therapy 

Circio Holding and Avenue Biosciences have entered a research collaboration to combine their synergistic technologies to improve long-term expression of secreted proteins, relevant for treatment of a broad range of diseases.  Secreting proteins from cells into surrounding tissue, or into circulation, opens new treatment opportunities beyond classical gene therapy for… Read More

#News

Female scientist in the lab
#Drug design #Nuclera #Proteins

Nuclera and leadXpro to design drugs for membrane proteins 

Biotechnology company Nuclera has partnered with leadXpro on structure-based drug design for complex membrane proteins.  The collaboration will bring together Nuclera’s eProtein Discovery system with leadXpro’s AI/ML-driven construct design and membrane protein expertise to advance structural studies and therapeutic development.  Membrane proteins remain some of the most valuable yet difficult to obtain drug targets. The proteins are notoriously challenging… Read More

#News

#Case study #Drug discovery #JAK inhibitor #Molecular dynamics #Proteins

Case study: Identifying ‘new’, active ligands for TYK2

A new Case Study is now available to download from Cresset. In this Case Study, the authors test the predictive abilities of Free Energy Perturbation (FEP) to arrive at accurate binding free energies for ‘new’ ligand suggestions within the TYK2 system. Computational methods used include: Molecular Dynamics (MD) Water… Read More

#News

#Drug discovery #JAK inhibitor #Molecular dynamics #Proteins

A Free Energy Perturbation (FEP) study: Identifying ‘new’, active ligands for TYK2

In this Case Study, we test the predictive abilities of Free Energy Perturbation (FEP) to arrive at accurate binding free energies for ‘new’ ligand suggestions within the TYK2 system. Computational methods used include: Molecular Dynamics (MD) Water analysis solving the Ornstein-Zernike equation (3D-RISM) Alignment of ligands for FEP (Conformation Hunt… Read More

#Case Studies #Resources

amino acids chain
#New facility #Protein design #Proteins #University of Copenhagen

New Danish research centre “a powerhouse for protein design”

A new Center for Protein Design (CPD) will open in August 2025 at the University of Copenhagen with a DKK 700 ($110) million grant from the Novo Nordisk Foundation.  The CPD hopes to spearhead developments in protein design and its applications through interdisciplinary collaborations across the university… Read More

#News

#Cytiva #Drug development #Nuclera #Proteins

Nuclera and Cytiva team up to accelerate protein production

Biotechnology company Nuclera and life sciences organisation Cytiva have announced a collaboration focused on accelerating the production, purification and characterisation of proteins required for drug research and development. The companies aim to enable this goal through the combination of Nuclera’s eProtein Discovery System with Cytiva’s Biacore surface plasmon resonance (SPR) technology. Read More

#News

Human cells
#Cancer research #Clinical research #Molecular Biology #Proteins

New resource could speed up the development of new drugs

Scientists have obtained new data on many of the proteins responsible for regulating the cell cycle – a sequence of molecular events that culminates in the production of two daughter cells. A dysregulated cell cycle is a hallmark of several diseases, including cancer. This information will not only provide the… Read More

#News

#Cancer drug targets #Cancer research #Oncology #Proteins #Surfaceome

Shining a light on the surfaceome – the new frontier in cancer drug discovery

Reece Armstrong examines the advances being made in identifying cell surface proteins and what this means for cancer drug discovery. There have been some landmark FDA approvals in recent years – but not everyone has picked up on the significance of its decision to green-light Merus’ lung and pancreatic cancer… Read More

#Cancer Research #Exclusive Content

#Biologics #Cell line development #Cell lines #Drug discovery #Proteins

Where do we stand with cell line development?

DDW’s Megan Thomas examines the value and impact of cell line development in the drug discovery industry. When it comes to the creation of biologics, cell line development is an essential drug discovery process. From a functional perspective, when it comes to monoclonal antibodies (mAbs), enzymes, or other therapeutic proteins,… Read More

#Exclusive Content

Blood samples in lab
#blood #Clinical trial #Fc-Fusion proteins #Proteins #Rare disease #Thrombotic diseases

First patients dosed in thrombolytic drug trial

TargED Biopharmaceuticals, a biotechnology company focused on developing improved treatments for thrombotic diseases, has dosed the first participant with TGD001. TGD001 is a thrombolytic designed to break down clots of all sizes and compositions – from large clots which cause AIS, down to ‘micro-clots’ which cause conditions such as the… Read More

#News

#CRISPR #DNA #Gene editing #mRNA #Proteins #SCIEX

Gene therapy: The quest for cures requires analytics to keep up

This article is sponsored by SCIEX. A new era of medicine has entered clinics with drugs against sickle cell anaemia or gene-related deafness, and many more gene therapy drugs are in different stages of development. These novel approaches go beyond treating symptoms; they aim to cure diseases. However, the diversity… Read More

#News

Zika virus
#Antivirals #Immunology / Virology & Vaccines #Juntendo University #Proteins

New understanding of Flaviviruses suggests novel treatment strategies

Researchers have uncovered how Flaviviruses like Dengue and Zika propagate, suggesting the possibility of new treatment strategies. They have identified a transporter protein, called importin-7 (IPO7), as crucial for the nuclear transport of Flaviviridae core proteins. Viruses of the family Flaviviridae, including Japanese encephalitis… Read More

#News

GBP pound sterling funding
#Funding #Innovate UK #Nuclera #Proteins

Nuclera receives £1.14m for eProtein Discovery platform

Biotech Nuclera has been awarded two Innovate UK grants totalling £1.14 ($1.4) million to further develop its eProtein Discovery platform. The funding is made up of a flexible, agile, scalable, and sustainable technologies (FASST) grant awarded in collaboration with DeepMirror, and an Engineering Biology grant. Read More

#News

Antibodies attacking virus
#Biomarkers #Drug discovery #Omics #Podcast #Proteins #Proteomics

Advancing precision medicine: Sengenics i-Ome Discovery microarrays

Professor Jonathan Blackburn, Chief Scientific Officer (CSO) of Sengenics, featured in a sponsored DDW Sitting Down With podcast to discuss the advantages of functional protein microarrays, challenges to overcome for biomarker discovery, Sengenics’ new i-Ome Discovery chip, and more. Professor Blackburn began by sharing an overview… Read More

#Exclusive Content